• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

New Delhi, March 16

The National Pharmaceutical Pricing Authority (NPPA) has revised the guidelines for non-scheduled drugs, and brought down the limit for annual price hikes from 20 per cent to 10 per cent.

The remaining criteria would be the same. The new rule applies to formulation packs with an annual turnover of over Rs 1 crore and for those that occupy more than 20 per cent of the market share, or are among the top three selling formulations in their segment. The price monitoring will continue to be on the basis of ORG IMS data, said the Authority in an official release. Non-compliance will call for action against the company. Further, the NPPA is reported to have upwardly revised the rates of 118 drugs by 12.46 per cent during the current fiscal and brought down the rates of 298 medicines by an average 31.46 per cent.

More Stories on : Pharmaceuticals | Regulatory Bodies & Rulings

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
TN's bundled wind energy project gets validation

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line